4 unchanged sentences
Holders of Record
−Removed: As of March 5, 2021, there were approximately 108 stockholders of record of our common stock, which does not include shares held in street name.
+Added: As of February 21, 2022, there were approximately 30 stockholders of record of our common stock, which does not include stockholders who hold shares in street name.
Dividend Policy
7 unchanged sentences
Recent Sales of Unregistered Equity Securities
−Removed: On December 11, 2020, we issued 209,238 shares of our common stock to SH Castle Biosciences, LLC upon the net exercise of a warrant to purchase 209,243 shares of common stock at an exercise price of approximately $0.001 per share.
−Removed: Additionally, we paid $41 in cash to SH Castle Biosciences, LLC for the value of a fractional share of common stock computed in connection with such net exercise.
−Removed: The net exercise was based on a fair market value of our common stock of $59.16 per share and did not result in any cash proceeds to us.
−Removed: On December 29, 2020, we issued an aggregate of 31,814 shares of our common stock to OTA LLC upon the net exercise of certain warrants to purchase an aggregate of 35,237 shares of common stock at an exercise price of approximately $7.10 per share.
−Removed: The warrants were originally issued to Oxford Finance LLC on March 31, 2017 and November 30, 2018, but were later transferred to OTA LLC in August 2020.
−Removed: We paid an aggregate of $58 in cash to OTA LLC for the value of fractional shares computed in connection with such net exercises.
−Removed: In accordance with the terms of the warrants, the net exercises were based on the fair market value of our common stock on the business day immediately prior to the date of delivery of the exercise notices, in each case $73.05 per share, and did not result in any cash proceeds to us.
−Removed: The issuances of these shares of common stock were deemed to be exempt from registration under the Securities Act in reliance on Section 4(a)(2) (or Regulation D promulgated thereunder) in that the issuance of securities was to an accredited investor and did not involve a public offering.
−Removed: The recipient of securities in each of these transactions acquired the securities for investment only and not with a view to or for sale in connection with any distribution thereof and appropriate legends were affixed to the securities issued in these transactions.
−Removed: The recipient of the securities in these transactions was an accredited investor under Rule 501 of Regulation D.
Use of Proceeds from IPO of Common Stock
−Removed: On July 29, 2019, we completed the initial public offering of our common stock, or the IPO, pursuant to which we issued and sold 4,600,000 shares of our common stock, including 600,000 shares associated with the full exercise of the underwriters’ option to purchase additional shares, at a price to the public of $16.00 per share.
+Added: On July 29, 2019, we completed the initial public offering of our common stock (our “IPO”), pursuant to which we issued and sold 4,600,000 shares of our common stock, including 600,000 shares associated with the full exercise of the underwriters’ option to purchase additional shares, at a price to the public of $16.00 per share.
The offer and sale of all of the shares of our common stock in the IPO were registered under the Securities Act pursuant to our Registration Statements on Form S-1, as amended (File Nos.
333-232369 and 333-232796), which were declared or became effective on July 24, 2019.
−Removed: SVB Leerink LLC and Robert W.
−Removed: Incorporated acted as joint book-running managers for the IPO and as representatives of the underwriters.
−Removed: Canaccord Genuity LLC and BTIG, LLC acted as co-managers for the IPO.
−Removed: We received gross proceeds from the IPO of $73.6 million, or net proceeds of $65.9 million after deducting $5.2 million in underwriting discounts and commissions and $2.5 million of offering expenses.
−Removed: None of the underwriting discounts and commissions or offering expenses were incurred or paid, directly or indirectly, to any of our directors or officers or their associates or to persons owning 10% or more of our common stock or to any of our affiliates.
There has been no material change in our planned use of the net proceeds from the IPO as described in the final prospectus filed with the SEC on July 26, 2019 relating to our Registration Statements on Form S-1 (File Nos.
3 unchanged sentences
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
−Removed: Selected Financial Data.
−Removed: Not required for smaller reporting companies.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.